We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALMOF market cap is 0. The company's latest EPS is TWD and P/E is N/A.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | |
| Total Revenue | 1.74B | 1.18B | 1.15B | 1.49B | 1.61B |
| Operating Income | 37.02M | -91.22M | -11.44M | 185.8M | -4.67M |
| Net Income | 81.45M | -103.57M | -42.92M | 240.11M | 51.51M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | |
| Total Assets | 2.68B | 2.83B | 2.77B | 4.02B | 4.87B |
| Total Liabilities | 253.46M | 412.65M | 419.31M | 448.68M | 728.24M |
| Total Equity | 2.42B | 2.42B | 2.35B | 3.57B | 4.14B |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | |
| Operating | -74.22M | 243.87M | 269.28M | -59.82M | -5.44M |
| Investing | 45.75M | -85.82M | -78.26M | -270.92M | 34.51M |
| Financing | -79.09M | -122.41M | -181.01M | 827.05M | -252.51M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 964.84M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Alphamab Oncology (PK) |
| Address |
9f., no. 66, sanchong rd taipei |
| Website | https://www.alcormicro.com |
| Industry | semiconductor,related device (3674) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
